Radiofrequency ablation of unresectable hepatic tumors.  [electronic resource] 

 -  TEC bulletin  Nov 2003 
 - 19-23 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1543-1622 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blue Cross Blue Shield Insurance Plans<br/>Catheter Ablation--adverse effects<br/>Device Approval<br/>Humans<br/>Insurance Coverage<br/>Liver Neoplasms--secondary<br/>Neoplasm Recurrence, Local<br/>Outcome Assessment, Health Care<br/>Randomized Controlled Trials as Topic<br/>Technology Assessment, Biomedical<br/>United States<br/>United States Food and Drug Administration